Ultragenyx Pharmaceutical RARE
$ 47.18
2.52%
Quarterly report 2024-Q3
added 11-16-2024
Ultragenyx Pharmaceutical EV/EBITDA Ratio 2011-2024 | RARE
Annual EV/EBITDA Ratio Ultragenyx Pharmaceutical
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-16.2 | -24.3 | -6.2 | -6.59 | -6.92 | -10.3 | -13.5 | -29.4 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-6.2 | -29.4 | -14.2 |